D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BID
3326
PUT
DELISTED
Sotheby's
BID
| $219K | ﹤0.01% |
5,800
-9,200
| -61% | -$369K |
|
|
EPE
3327
DELISTED
EP Energy Corporation
EPE
| $219K | ﹤0.01% |
839,657
-12,101
| -1% | -$8.02K |
|
3328
Federated Hermes
FHI
$4.4B
| $218K | ﹤0.01% |
+7,433
| New | +$206K |
|
|
AVH
3329
DELISTED
AVIANCA HOLDINGS S.A.
AVH
| $218K | ﹤0.01% |
53,286
+17,973
| +51% | +$82.1K |
|
|
DOC
3330
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $218K | ﹤0.01% |
11,615
-208,957
| -95% | -$3.72M |
|
|
SAVE
3331
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $217K | ﹤0.01% |
+4,100
| New | +$236K |
|
3332
PUT
Logitech
LOGI
$15.2B
| $216K | ﹤0.01% |
+5,500
| New | +$198K |
|
|
AUO
3333
DELISTED
AU Optronics Corp
AUO
| $216K | ﹤0.01% |
59,302
-141,075
| -70% | -$536K |
|
3334
Lindblad Expeditions
LIND
$1.76B
| $215K | ﹤0.01% |
14,077
-19,786
| -58% | -$269K |
|
|
BSTC
3335
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $215K | ﹤0.01% |
3,450
-4,354
| -56% | -$288K |
|
3336
CALL
Deluxe
DLX
$1.19B
| $214K | ﹤0.01% |
+4,900
| New | +$220K |
|
|
PDM
3337
Piedmont Realty Trust
PDM
$1.22B
| $214K | ﹤0.01% |
10,257
-90,350
| -90% | -$1.78M |
|
3338
WEC Energy
WEC
$37.7B
| $214K | ﹤0.01% |
+2,700
| New | +$200K |
|
|
BRG
3339
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $213K | ﹤0.01% |
19,725
+8,325
| +73% | +$86.8K |
|
|
GMS
3340
PUT
DELISTED
GMS Inc
GMS
| $212K | ﹤0.01% |
14,000
-18,500
| -57% | -$334K |
|
3341
CALL
Cheniere Energy
LNG
$56.5B
| $212K | ﹤0.01% |
+3,100
| New | +$204K |
|
|
WLL
3342
DELISTED
Whiting Petroleum Corporation
WLL
| $212K | ﹤0.01% |
108
-1,520
| -93% | -$3.06M |
|
3343
Canadian Solar
CSIQ
$906M
| $210K | ﹤0.01% |
+11,253
| New | +$231K |
|
3344
Oxford Industries
OXM
$577M
| $210K | ﹤0.01% |
+2,794
| New | +$215K |
|
|
CPE
3345
PUT
DELISTED
Callon Petroleum Company
CPE
| $210K | ﹤0.01% |
+2,780
| New | +$215K |
|
3346
CALL
Timken Company
TKR
$9.82B
| $209K | ﹤0.01% |
+4,800
| New | +$204K |
|
3347
L3Harris
LHX
$55.9B
| $208K | ﹤0.01% |
1,300
-1,400
| -52% | -$216K |
|
3348
CALL
Southwest Airlines
LUV
$22.1B
| $208K | ﹤0.01% |
+4,000
| New | +$211K |
|
3349
Ooma
OOMA
$550M
| $208K | ﹤0.01% |
15,679
-14,089
| -47% | -$212K |
|
3350
NNN REIT
NNN
$9.39B
| $205K | ﹤0.01% |
3,705
-92,203
| -96% | -$4.78M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.